Similar incidence of stroke with SGLT2 inhibitors and GLP-1 receptor agonists in real-world cohort studies among patients with type 2 diabetes

Similar incidence of stroke with SGLT2 inhibitors and GLP-1 receptor agonists in real-world cohort studies among patients with type 2 diabetes

Background: Stroke represents a major burden in patients with type 2 diabetes. Yet, this cerebrovascular complication has been less well studied than coronary artery disease and heart failure. Some cardiovascular outcome data suggested that sodium-glucose cotransporter 2 inhibitors (SGLT2is) exert a...

Full description

Bibliographic Details
Main Author: André J. Scheen
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:Diabetes Epidemiology and Management
Subjects:
GLP-1 receptor agonist
Observational cohort study
Meta-analysis
Real-world evidence
SGLT2 inhibitor
Stroke
Online Access:http://www.sciencedirect.com/science/article/pii/S2666970623000586

Internet

http://www.sciencedirect.com/science/article/pii/S2666970623000586

Similar Items